Human factors research in the support of medical and drug delivery device commercialization is essential and we should be planning on a return to in-person research as soon as is possible by applying all available and practical protective measures.
Back to team page
Lucy Tootill
Senior UX Researcher
Lucy has more than a decade of experience in clinical operations and finance. Clients benefit from her passion for working with people of diverse backgrounds and drive to put people at the center of the research. Lucy loves to dig for the “why” under complicated problems and is driven to find the balance between user needs and business goals in each project. Lucy holds a BA in Political Science from California State University, Los Angeles.
Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight:

In your spare time (or if you had spare time), you would absolutely do this:

Your favorite city in the world is...and why?

You cannot start the day without doing this:

Favorite TV show:
Best piece of advice you’ve been given:

Any other facts to share?
Read our team’s latest bold insights
COVID-19: Using human factors and UX to make a positive impact
We have aggregated some considerations for HCPs, healthcare organizations, and others involved in the medical space.
Is FMEA inadequate for human factors analyses?
A “traditional” risk assessment does not meet the needs of FDA-required human factors analyses.
Pros and cons of remote moderated testing: Considerations for ongoing research during COVID-19
A few key adjustments can help capture research data effectively and ensure the health of participants and team members.